SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NXGN, AVTA, AGE, THRN
NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
NextGen Healthcare, Inc. (NASDAQ: NXGN)’s sale to Thoma Bravo for $23.95 per share in cash. If you are a NextGen shareholder, click here to learn more about your rights and options.
Avantax, Inc. (NASDAQ: AVTA)’s sale to Cetera Holdings for $26.00 in cash per share. If you are an Avantax shareholder, click here to learn more about your rights and options.
AgeX Therapeutics, Inc. (NYSE: AGE)’s merger with Serina Therapeutics, Inc. Upon completion of the merger, pre-merger AgeX stockholders are expected to own approximately 25% of the newly combined company. If you are an AgeX shareholder, click here to learn more about your rights and options.
Thorne HealthTech, Inc. (NASDAQ: THRN)’s sale to L Catterton for $10.20 per share in cash. If you are a Thorne shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.